Science Magazine Names USAID-Funded HIV Research As Top 10 Breakthrough Of The Year
The HIV prevention trials were conducted by the Center for the AIDS Program of Research in South Africa (CAPRISA) with assistance from two USAID-funded implementing partners, Family Health International (FHI) and CONRAD. Researchers of the study tested the use of a vaginal gel containing 1% of the anti-HIV drug tenofovir. The drug was administered over a 30-month period to 889 South African women and was proven to reduce HIV infections by 39 percent.
The microbicide trial exemplifies USAID's commitment to supporting game-changing breakthroughs in global health, and also to focus on women and gender equality, both of which will expand under President Obama's Global Health Initiative. Further, USAID is committed to building a solid foundation of robust science and new technologies, enabling innovation to redefine and strengthen U.S. development assistance globally.
Notably, the microbicide study was one of two breakthroughs in HIV/AIDS prevention recognized in the Top 10 list. Science Magazine also recognized the Pre-Exposure Prophylaxis Initiative (iPrEx) study, which confirmed that daily oral use of a combination antiretroviral (ARV), Truvada reduced the risk of HIV infection by 44 percent among men who have sex with men. This historic iPrEx trial provides the first proof of concept that oral PrEP of an ARV can prevent HIV transmission.
USAID is looking to complement the iPrEx results with a similar study for women. The FemPrEP clinical trial led by FHI with support from USAID is designed to test the safety and effectiveness of a daily dose of Truvada for HIV prevention. Finding a woman-controlled method of prevention is critical in the fight against HIV/AIDS.
Source: U.S. Agency for International Development
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
U.S. Agency for International Development. "Science Magazine Names USAID-Funded HIV Research As Top 10 Breakthrough Of The Year." Medical News Today. MediLexicon, Intl., 28 Dec. 2010. Web.
21 Feb. 2017. <http://www.medicalnewstoday.com/releases/212499.php>
U.S. Agency for International Development. (2010, December 28). "Science Magazine Names USAID-Funded HIV Research As Top 10 Breakthrough Of The Year." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.